Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

May 28, 2009 09:30 ET

Meridian Signs Distributor for the Tri-States

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 28, 2009) - Meridian Medical Inc., North American exclusive distributor for Meridian Co., Ltd. (OTCBB:MRDAF), a company engaged in the research, development, manufacturing, and sales of advanced medical devices, is pleased to announce that they have signed a multi-million dollar agreement with LipoLaser USA as a distributor for Ohio, Indiana and Kentucky State.

Upon execution of the contract, LipoLaser USA has purchased an initial order of 10 units of the Lapex 2000 BCS and is committed to purchase an additional 90 units over the next 2 1/2 years.

The President and CEO of LipoLaser USA Bob Arrasmith opened the first LipoLaser clinic in October of 2008, and he is already expanding into the Tri-State area of Indiana, Ohio and Kentucky. "We are extremely excited about the future of our companies. It would appear our LipoLaser Clinic is a recession proof business based on our last 6 months," says Arrasmith. "These are some pretty tough economic times, but our business is not just thriving, we are expanding." Mark Goetz of MHG Leasing, a shareholder of LipoLaser USA, has provided leasing options for individuals looking to incorporate the device into their business model. LipoLaser USA is located in the Chamber of Commerce Center, Ft. Mitchell, Kentucky.

"It is extremely important that our distribution partners share our goals and have the ability to provide customers with first class service, support, and distribution. Mr. Arrasmith, President of LipoLaser USA clearly fits the criteria we identified to promote our products effectively," said Robert J. Krznaric, CEO of Meridian Medical Inc.

Meridian is a leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 5 patents on its technology, and has received FDA approval, Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe. Meridian continues to successfully market its superior product line to a growing number of clients worldwide.

This press release contains certain forward-looking information and statements concerning the company's future operations, performance and financial condition. These statements include that the Lapex BCS is a safe and pain free, non-invasive laser device; that FDA clearance is an important step in the ongoing marketing and development of Meridian's industry leading equipment; and that Meridian continues to successfully market its superior product line to a growing number of clients worldwide. Forward looking statements are subject to a number of risks, uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Risk factors which could prevent the foregoing statements from being accurate include possible accidents of use of our laser devices and possible lesser market acceptance of our medical devices than anticipated. The Company does not update its forward looking information. This document is not intended to be and is not an advertisement for any securities of the Company.

Contact Information